Accession Therapeutics
The Oxford company is developing novel immuno-oncology therapeutics combining high specificity and potency with the ability to counter tumour diversity.
Oxford, UKaccessiontherapeutics.com ↗
Total raised
€19M
€19,193,791
Funding rounds
1
Investors
3
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-28 | Other | €19M | Birk Venture,iGlobe Partners,Primavera Venture Partners | View deal → |
Related news
- £16.6m raised by cancer-fighting startup Accession Therapeuticsbusinesscloud.co.uk · 2022-11